Universal Health Services (UHS) has drawn investor attention after its share price closed at US$168.64. The stock has declined over the past month and past 3 months despite recent growth in revenue.
See our latest analysis for Universal Health Services.
Recent moves show momentum has softened, with the share price down 7.55% over the past 30 days and 28.27% over 90 days, while the 3 year total shareholder return of 26.42% still reflects a much stronger longer term outcome.
If this healthcare stock has you reassessing where growth could come from next, it might be worth scanning for other potential opportunities using our list of 28 healthcare AI stocks
With Universal Health Services shares under pressure despite revenue growth and a value score of 6, the key question is whether this healthcare stock is trading at a discount or whether the market is already pricing in its future growth.
Most Popular Narrative: 24.9% Undervalued
According to the most followed narrative, Universal Health Services has a fair value of $224.48 compared with the last close at $168.64, pointing to a sizeable valuation gap that rests heavily on its role in behavioral healthcare.
UHS operates one of the largest behavioral health hospital networks in the country, alongside a substantial acute care segment. That dual exposure gives the company a stabilizing balance: acute care supports cash flow consistency, while behavioral health provides structural growth driven by demographics, policy shifts, and unmet clinical need. Over time, this combination has proven resilient across economic cycles, making UHS a frequent reference point when investors look for defensiveness paired with growth.
Want to see how this narrative gets to that higher fair value? It leans heavily on behavioral health demand, margin resilience, and a future earnings profile that treats UHS more like a compounder than a slow grower.
Result: Fair Value of $224.48 (UNDERVALUED)
Have a read of the narrative in full and understand what’s behind the forecasts.
However, this depends on continued behavioral health demand and stable reimbursement. Any sustained pressure on margins or earnings expectations could quickly challenge that undervaluation narrative.
Find out about the key risks to this Universal Health Services narrative.
Next Steps
With mixed sentiment around risk and reward, now is a good time to look through the numbers yourself, weigh both sides, and see whether the 4 key rewards and 2 important warning signs
Looking for more investment ideas?
If you stop with just one stock, you could miss other compelling setups that better fit your risk, income, or value goals, so broaden your search now.
This article by Simply Wall St is general in nature. We provide commentary based on historical data
and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your
financial situation. We aim to bring you long-term focused analysis driven by fundamental data.
Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.
Simply Wall St has no position in any stocks mentioned.
New: AI Stock Screener & Alerts
Our new AI Stock Screener scans the market every day to uncover opportunities.
• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies
Or build your own from over 50 metrics.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com